Interstitial Lung Disease and Chemical Exposure
Interstitial lung disease (ILD) encompasses a group of progressive fibrotic lung conditions, including idiopathic pulmonary fibrosis (IPF). Occupational chemical exposures—particularly in fluoropolymer manufacturing—have been linked to ILD development in exposed workers, with PFAS as potential contributors beyond the better-characterized fibrogenic dusts.
Fluoropolymer Fever and Lung Toxicity
Polymer fume fever—an occupational syndrome caused by inhaling fumes from overheated fluoropolymers—causes acute respiratory inflammation and systemic symptoms. Repeated low-level exposure to fluoropolymer processing emissions may cause chronic pulmonary inflammation leading to fibrotic changes in the lung parenchyma over years of occupational exposure.
TGF-Beta Activation in Lung Tissue
PFAS compounds activate TGF-beta signaling in pulmonary fibroblasts, promoting collagen deposition and myofibroblast differentiation. These cellular changes parallel IPF pathogenesis, suggesting that occupational PFAS exposure could accelerate or initiate fibrotic lung disease in genetically susceptible individuals.
Occupational Medicine Assessment
Pulmonologists evaluating ILD in fluorochemical industry workers should document comprehensive occupational PFAS exposure history. High-resolution CT showing honeycomb pattern or UIP pattern in workers with significant fluoropolymer exposure should prompt both diagnostic workup and workplace exposure reduction measures.